TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as "Elix") commenced joint ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback